Abstract
Pathological processes like cancer, chronic inflammation and autoimmune phenomena, all of which involve massive cell death, are associated with significant increases in circulating DNA. In order to clarify whether massive apoptosis occurring under physiological circumstances also causes DNA release into the circulation, we correlated the time-course of dexamethasone-induced intra thymic cell apoptosis with plasma DNA dynamics in rats. Animals were given 10 mg/l dexamethasone in their drinking water for up to 7 days. Sequential plasma samples were obtained during the treatment and DNA was quantitated by a micro fluorometric assay. Thymus and spleen weight as well as apoptotic cell levels were assessed at different times. Seven days of glucocorticoid treatment reduced thymic and spleen mass by 82 and 31%, respectively. Intra thymic apoptosis was maximal 24 h after the beginning of glucocorticoid treatment, declining markedly by 48 h. Very little apoptosis was observed in the spleen. Plasma DNA increased steadily during the first 4 days of glucocorticoid treatment (11.8 ± 1.2 μg/ml on day 0; 24.2 ± 1.6 μg/ml on day 4) beginning to decline afterward. Thymectomy but not splenectomy, drastically reduced the glucocorticoid-induced increase in plasma DNA. It is concluded that hormone-induced massive intra thymic cell death is followed by a delayed release of nucleosomal DNA into the circulation.
Similar content being viewed by others
References
Beaulaton J, Lockshin RA. The relation of programmed cell death to development and reproduction: Comparative studies and an attempt at classification. Int Rev Cytol 1982; 79: 215–235.
Wyllie AH. Cell death: The significance of apoptosis. Int Rev Cytol 1980; 68: 251–306.
Cotter TG, Lennon SV, Glynn JG, Martin SJ. Cell death via apoptosis and its relationship to growth, development and differentiation of both tumour and normal cells. Anticancer Res 1990; 10: 1153–1160.
Kerr JFR, Wyllie AH, Currie AR. Apoptosis:Abasic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–257.
Kerr JF, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994; 73: 2013–2026.
Arends MJ, Morris RJ, Wyllie AH. Apoptosis: The role of endonuclease. Am J Pathol 1990; 136: 593–608.
Kornberg R. Structure of the chromatin. Annu Rev Biochem 1977; 46: 931–954.
Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2,8 A resolution. Nature (London) 1997; 389: 251–260.
Wyllie AH. Death from inside out: An overview. Philos Trans Royal Soc Lond 1994; 345: 237–241.
Steinman CR. Free DNA in serum and plasma from normal adults. J Clin Invest 1975; 56: 512–515.
Shapiro B, Chakrabarty M, Cohn EM, Leon SA. Determination of circulating DNAlevels in patients with benign or malignant gastrointestinal disease. Cancer 1983; 51: 2116–2120.
Raptis L, Menard HA. Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Invest 1980; 66: 1391–1399.
Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977; 37: 646–650.
Fournié GJ, Courtin JP, Laval F, et al. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 1995; 91: 221–227.
Maebo A. Plasma DNA level as a tumor marker in primary lung cancer. Nihon Kyobu Shikkan Gakkai Zasshi 1990; 28: 1085–1091.
Anker P. Quantitative aspects of plasma/serum DNA in cancer patients. Ann NY Acad Sci USA 2000; 906: 5–7.
Koffler D, Agnello V, Winchester R, Kunkel HG. The occurrence of single-stranded DNA in the serum of patients with SLE and other diseases. J Clin Invest 1973; 52: 198–204.
Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Amer J Pathol 1995; 146: 3–15.
Brunk CF, Jones KC, James TW. Assay for nanogram quantities of DNA in cellular homogenates. Anal Biochem 1978; 92: 497–500.
Quaglino D, Ronchetti P. Cell death in the rat thymus: A minireview. Apoptosis 2001; 6: 389–401.
Ahmed SA, Sriranganathan N. Differential effects of dexamethasone on the thymus and spleen: Alterations in programmed cell death, lymphocyte subsets and activation of T cells. Immunopharmacol 1994; 28: 55–66.
Holdenrieder S, Stieber P, Bodenmüller H, et al. Nucleosomes in serum of patients with benign and malignant diseases. Int J Cancer (Pred Oncol) 2001; 95: 114–120.
Rumore P, Muralidhar B, Lin M, Lai C, Steinman CR. Haemodialysis as a model for studying endogenous plasma DNA: Oligonucleosome-like structure and clearance. Clin exp Immunol 1992; 90: 56–62.
Gauthier VJ, Tyler LN, Mannik M. Blood clearance kinetics and liver uptake of mononucleosomes in mice. J Immunol 1996; 156: 1151–1156.
Odaka C, Mizuochi T. Macrophages are involved in DNA degradation of apoptotic cells in murine thymus after administration of hydrocortisone. Cell Death Differ 2002; 9: 104–112.
Jacob L, Viard JP, Allenet B, et al. A monoclonal anti-doublestranded DNA autoantibody binds to a 94-kDa cell-surface protein on various cell types via nucleosomes or a DNAhistone complex. Proc Natl Acad Sci USA 1989; 86: 4669–4673.
Hefeneider SH, Cornell KA, Brown LE, Bakke AC, McCoy SL, Bennet RM. Nucleosomes and DNA bind to specific cellsurface molecules on murine cells and induce cytokine production. Clin Immunol Immunopathol 1992; 63: 245–251.
Bell DA, Morrison B, Vanden Bygaart P. Immunogenic DNA-related factors. J Clin Invest 1990; 85: 1487–1496.
Atkinson MJ, Bell DA, Singhal SK. Anaturally occurring polyclonal B cell activator of normal and autoantibody responses. J Immunol 1985; 135(4): 2524–2533.
Le Lann AD, Fournié GJ, Boissier L, Toutain PL, Benoist H. In vitro inhibition of natural killer-mediated lysis by chromatin fragments. Cancer Immunol Immunother 1994; 39: 185–192.
McCroskey MC, Palazuk BJ, Pierce-Ramsey PA, Colca JR, Pearson JD. Insulin-like effects of histones H3 and H4 on isolated rat adipocytes. Biochim Biophys Acta 1989; 1011: 212–219.
Reichhart R, Zeppezauer M, Jörnvall H. Preparations of homeostatic thymus hormone consist predominantly of histones 2A and 2B and suggest additional histone functions. Proc Natl Acad Sci USA 1985; 82: 4871–4875.
Goya RG, Quigley KL, Takahashi S, Reichhart R, Meites J. Differential effect of homeostatic thymus hormone on plasma thyrotropin and growth hormone in young and old rats. Mech Age Devel 1989; 49: 119–128.
Goya RG, Sosa YE, Quigley KL, Reichhart R, Meites J. Homeostatic thymus hormone stimulates corticosterone secretion in a dose-and age-dependent manner in rats. Neuroendocrinology 1990; 51: 59–63.
Brown OA, Sosa YE, Goya RG. Thyrotropin-releasing activity of histones H2A, H2B and peptide MB35. Peptides 1997; 18(8): 1315–1319.
Brown, OA, Sosa YE, Goya RG. Histones as extracellular messengers: Effects on growth hormone secretion. Cell Biol Int 1997; 21(12): 787–792.
Brown OA, Sosa YE, Goya RG. Gonadotrophin-releasing activity of histones H2A and H2B. Cell Molec Life Sci 1998; 54: 288–294.
Brown OA, Sosa YE, Castro MG, Goya RG. Studies on the prolactin-releasing mechanism of histones H2A and H2B. Life Sci 2000; 66: 2081–2089.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goya, R.G., Cónsole, G.M., Spinelli, O.M. et al. Glucocorticoid-induced apoptosis in lymphoid organs is associated with a delayed increase in circulating deoxyribonucleic acid. Apoptosis 8, 171–177 (2003). https://doi.org/10.1023/A:1022922726418
Issue Date:
DOI: https://doi.org/10.1023/A:1022922726418